• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

检测 SARS-CoV-2 抗体不足以诊断活动性或已治愈的 COVID-19。

Detection of SARS-CoV-2 antibodies is insufficient for the diagnosis of active or cured COVID-19.

机构信息

Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.

出版信息

Sci Rep. 2020 Nov 16;10(1):19893. doi: 10.1038/s41598-020-76914-5.

DOI:10.1038/s41598-020-76914-5
PMID:33199713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7669901/
Abstract

We assessed the performance of Abbott's SARS-CoV-2 IgG assay and the Panbio COVID-19 IgG/IgM rapid test device for the diagnosis of either active or cured COVID-19. Three cohorts of patients were chosen. Cohort 1, patients (n = 65) who attended the emergency department on March 30, 2020 with clinical suspicion of active COVID-19 (n = 56 with proven/probable COVID-19). Cohort 2, hospital workers (n = 92) who had either been (n = 40) or not (n = 52) diagnosed with proven/probable COVID-19 and were asymptomatic at the time of the sampling. Cohort 3, patients (n = 38) cared at the hospital before the start of the COVID-19 pandemic. Detection of serum antibodies was done using Abbott´s SARS-CoV-2 IgG assay and the Panbio COVID-19 IgG/IgM device. Both methods showed 98% agreement for IgG detection. No antibodies were detected in the 38 samples from hospitalized pre-COVID subjects. The diagnostic performance of IgGs detected by Abbott´s SARS-CoV-2 assay in Cohorts 1/2 was: sensitivity (60.7%/75%) and specificity (100%/84.6%). The diagnostic performance of IgM by Panbio COVID-19 in Cohorts 1/2 was: sensitivity (16%/17.5%) and specificity (100%/98.1%). We show that IgG detection alone is insufficient for the diagnosis of active or cured COVID-19. IgM detection has a limited diagnostic value.

摘要

我们评估了雅培 SARS-CoV-2 IgG 检测试剂盒和 Panbio COVID-19 IgG/IgM 快速检测设备对现症或既往 COVID-19 的诊断性能。选择了三批患者。队列 1:2020 年 3 月 30 日因临床疑似现症 COVID-19 而就诊于急诊科的患者(56 例确诊/可能 COVID-19);队列 2:在采样时无症状且要么已确诊(40 例)要么未确诊(52 例)的医院工作人员;队列 3:在 COVID-19 大流行开始前在医院接受治疗的患者。使用雅培 SARS-CoV-2 IgG 检测试剂盒和 Panbio COVID-19 IgG/IgM 设备检测血清抗体。两种方法检测 IgG 的一致性为 98%。38 例 COVID-19 大流行前住院患者的样本中均未检测到抗体。雅培 SARS-CoV-2 检测试剂盒在队列 1/2 中检测 IgG 的诊断性能为:敏感性(60.7%/75%)和特异性(100%/84.6%)。Panbio COVID-19 在队列 1/2 中检测 IgM 的诊断性能为:敏感性(16%/17.5%)和特异性(100%/98.1%)。我们表明,单独检测 IgG 不足以诊断现症或既往 COVID-19。IgM 检测的诊断价值有限。

相似文献

1
Detection of SARS-CoV-2 antibodies is insufficient for the diagnosis of active or cured COVID-19.检测 SARS-CoV-2 抗体不足以诊断活动性或已治愈的 COVID-19。
Sci Rep. 2020 Nov 16;10(1):19893. doi: 10.1038/s41598-020-76914-5.
2
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic.2020年新冠疫情期间,在意大利北部一家大型教学医院,将严重急性呼吸综合征冠状病毒2型IgG/IgM快速检测作为住院患者和医护人员的诊断工具。
New Microbiol. 2020 Oct;43(4):161-165. Epub 2020 Oct 31.
3
Validation and performance comparison of three SARS-CoV-2 antibody assays.三种 SARS-CoV-2 抗体检测试剂盒的验证和性能比较。
J Med Virol. 2021 Feb;93(2):916-923. doi: 10.1002/jmv.26341. Epub 2020 Aug 13.
4
A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay. Abbott Panbio™ COVID-19 IgG/IgM 快速检测试剂盒与 Abbott Architect™ SARS-CoV-2 IgG 检测试剂盒的比较评估。
J Clin Virol. 2020 Nov;132:104645. doi: 10.1016/j.jcv.2020.104645. Epub 2020 Sep 16.
5
Comparative analysis of three laboratory based serological assays for SARS-CoV-2 in an Australian cohort.澳大利亚队列中三种基于实验室的 SARS-CoV-2 血清学检测方法的比较分析。
Pathology. 2020 Dec;52(7):764-769. doi: 10.1016/j.pathol.2020.09.008. Epub 2020 Sep 30.
6
Clinical evaluation of SARS-CoV-2 point-of-care antibody tests.新型冠状病毒即时检测抗体的临床评估。
Pathology. 2020 Dec;52(7):783-789. doi: 10.1016/j.pathol.2020.09.002. Epub 2020 Sep 22.
7
The reliability of SARS-CoV-2 IgG antibody testing - a pilot study in asymptomatic health care workers in a Croatian university hospital.新型冠状病毒 IgG 抗体检测的可靠性——克罗地亚一所大学医院中无症状医护人员的试点研究。
Croat Med J. 2020 Dec 31;61(6):485-490. doi: 10.3325/cmj.2020.61.485.
8
Diagnostic performance of immunochromatography assay for rapid detection of IgM and IgG in coronavirus disease 2019.免疫层析法快速检测 2019 年冠状病毒病 IgM 和 IgG 的诊断性能。
J Med Virol. 2020 Nov;92(11):2567-2572. doi: 10.1002/jmv.26060. Epub 2020 Jun 9.
9
Development of an enzyme-linked immunosorbent assay for the detection of IgG-antibodies to the causative agent of COVID-19 in human serum (plasma).开发一种用于检测人血清(血浆)中针对新冠病毒病原体的IgG抗体的酶联免疫吸附测定法。
Klin Lab Diagn. 2020 Dec 4;65(11):683-687. doi: 10.18821/0869-2084-2020-65-11-683-687.
10
Immunochromatographic test for differentiation detection of IgM and IgG to SARS-CoV-2.用于鉴别检测新型冠状病毒2型IgM和IgG的免疫层析试验。
Klin Lab Diagn. 2020 Dec 4;65(11):688-692. doi: 10.18821/0869-2084-2020-65-11-688-692.

引用本文的文献

1
Longitudinal soluble marker profiles reveal strong association between cytokine storms resulting from macrophage activation and disease severity in COVID-19 disease.纵向可溶性标志物谱揭示了 COVID-19 疾病中巨噬细胞激活引起的细胞因子风暴与疾病严重程度之间的强烈关联。
Sci Rep. 2024 Jun 5;14(1):12882. doi: 10.1038/s41598-024-63586-8.
2
PCR combined with serologic testing improves the yield and efficiency of SARS-CoV-2 infection hunting: A study in 40,689 consecutive overseas arrivals.PCR 联合血清学检测提高了 SARS-CoV-2 感染搜索的产量和效率:一项对 40689 例连续海外入境者的研究。
Front Public Health. 2023 Feb 13;11:1077075. doi: 10.3389/fpubh.2023.1077075. eCollection 2023.
3

本文引用的文献

1
Qualitative serology in patients recovered from SARS CoV 2 infection.从新冠病毒感染中康复患者的定性血清学研究。
J Infect. 2020 Aug;81(2):e120-e121. doi: 10.1016/j.jinf.2020.05.057. Epub 2020 May 28.
2
Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset.感染 SARS-CoV-2 后的血清学特征:暴露后及症状出现后。
Eur Respir J. 2020 Aug 27;56(2). doi: 10.1183/13993003.00763-2020. Print 2020 Aug.
3
The role of serology for COVID-19 control: Population, kinetics and test performance do matter.
Real-world performance of SARS-Cov-2 serology tests in the United States, 2020.
2020 年美国 SARS-CoV-2 血清学检测的真实世界表现。
PLoS One. 2023 Feb 3;18(2):e0279956. doi: 10.1371/journal.pone.0279956. eCollection 2023.
4
The correlation between IgM and IgG antibodies with blood profile in patients infected with severe acute respiratory syndrome coronavirus.严重急性呼吸综合征冠状病毒感染患者中IgM和IgG抗体与血液指标的相关性。
Clin Mol Allergy. 2022 Dec 22;20(1):15. doi: 10.1186/s12948-022-00180-1.
5
Immune Determinants of Viral Clearance in Hospitalised COVID-19 Patients: Reduced Circulating Naïve CD4+ T Cell Counts Correspond with Delayed Viral Clearance.住院 COVID-19 患者病毒清除的免疫决定因素:循环中幼稚 CD4+T 细胞计数减少与病毒清除延迟相对应。
Cells. 2022 Sep 2;11(17):2743. doi: 10.3390/cells11172743.
6
Microfluidic particle dam for direct visualization of SARS-CoV-2 antibody levels in COVID-19 vaccinees.用于直接可视化新冠疫苗接种者中SARS-CoV-2抗体水平的微流控颗粒坝
Sci Adv. 2022 Jun 3;8(22):eabn6064. doi: 10.1126/sciadv.abn6064.
7
Detection of silent infection of severe acute respiratory syndrome coronavirus 2 by serological tests.血清学检测法检测严重急性呼吸综合征冠状病毒 2 的隐匿性感染。
PLoS One. 2022 May 20;17(5):e0267566. doi: 10.1371/journal.pone.0267566. eCollection 2022.
8
High incidence of COVID-19 at nursing homes in Madrid, Spain, despite preventive measures.西班牙马德里养老院 COVID-19 发病率高,尽管采取了预防措施。
Rev Esp Quimioter. 2022 Jun;35(3):288-292. doi: 10.37201/req/008.2022. Epub 2022 Apr 11.
9
Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19.免疫球蛋白 G1 Fc 糖基化作为严重 COVID-19 的早期标志。
EBioMedicine. 2022 Apr;78:103957. doi: 10.1016/j.ebiom.2022.103957. Epub 2022 Mar 22.
10
Multiplexed flow cytometric approach for detection of anti-SARS-CoV-2 IgG, IgM and IgA using beads covalently coupled to the nucleocapsid protein.基于与核衣壳蛋白共价偶联的珠子的多重流式细胞术检测抗 SARS-CoV-2 IgG、IgM 和 IgA 的方法。
Lett Appl Microbiol. 2022 Jun;74(6):863-872. doi: 10.1111/lam.13674. Epub 2022 Feb 19.
血清学在新冠疫情防控中的作用:人群、动态变化及检测性能至关重要。
J Infect. 2020 Aug;81(2):e91-e92. doi: 10.1016/j.jinf.2020.05.019. Epub 2020 May 15.
4
Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs.用于检测鼻咽拭子中SARS-CoV-2抗原的快速诊断检测方法的评估
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00977-20.
5
Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho.雅培Architect SARS-CoV-2 IgG检测法的性能特征及爱达荷州博伊西市的血清阳性率
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00941-20.
6
Antibody responses to SARS-CoV-2 in patients with COVID-19.新型冠状病毒肺炎(COVID-19)患者的 SARS-CoV-2 抗体反应。
Nat Med. 2020 Jun;26(6):845-848. doi: 10.1038/s41591-020-0897-1. Epub 2020 Apr 29.
7
Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的免疫球蛋白G和IgM抗体概况
Clin Infect Dis. 2020 Nov 19;71(16):2255-2258. doi: 10.1093/cid/ciaa489.
8
The important role of serology for COVID-19 control.血清学在新冠疫情防控中的重要作用。
Lancet Infect Dis. 2020 Jul;20(7):758-759. doi: 10.1016/S1473-3099(20)30322-4. Epub 2020 Apr 21.
9
Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients.基于 COVID-19 患者疾病严重程度的核酸和血清学检测结果的不同纵向模式。
Emerg Microbes Infect. 2020 Dec;9(1):833-836. doi: 10.1080/22221751.2020.1756699.
10
Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.新型冠状病毒肺炎患者的抗体检测及动态特征。
Clin Infect Dis. 2020 Nov 5;71(8):1930-1934. doi: 10.1093/cid/ciaa461.